Carvedilol treatment of chronic heart failure: a new era

被引：3

作者：

Bristow, MR ^{[1
]}

机构：

[1] Univ Colorado, Hlth Sci Ctr, Div Cardiol, Denver, CO 80262 USA

来源：

HEART | 1998年 / 79卷

关键词：

D O I：

10.1136/hrt.79.2008.31S

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S31 / S34

页数：4

共 39 条

[1]

Asano K, 1997, CIRCULATION, V95, P1193

[2]

BRISTOW M R, 1989, Cardiovascular Drugs and Therapy, V3, P971

[3] Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure [J].

Bristow, MR ;

Gilbert, EM ;

Abraham, WT ;

Adams, KF ;

Fowler, MB ;

Hershberger, RE ;

Kubo, SH ;

Narahara, KA ;

Ingersoll, H ;

Krueger, S ;

Young, S ;

Shusterman, N .

CIRCULATION, 1996, 94 (11) :2807-2816

[4] DOSE-RESPONSE OF CHRONIC BETA-BLOCKER TREATMENT IN HEART-FAILURE FROM EITHER IDIOPATHIC DILATED OR ISCHEMIC CARDIOMYOPATHY [J].

BRISTOW, MR ;

OCONNELL, JB ;

GILBERT, EM ;

FRENCH, WJ ;

LEATHERMAN, G ;

KANTROWITZ, NE ;

ORIE, J ;

SMUCKER, ML ;

MARSHALL, G ;

KELLY, P ;

DEITCHMAN, D ;

ANDERSON, JL .

CIRCULATION, 1994, 89 (04) :1632-1642

[5] BETA-ADRENERGIC FUNCTION IN HEART-MUSCLE DISEASE AND HEART-FAILURE [J].

BRISTOW, MR ;

KANTROWITZ, NE ;

GINSBURG, R ;

FOWLER, MB .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1985, 17 :41-52

[6] PATHOPHYSIOLOGIC AND PHARMACOLOGICAL RATIONALES FOR CLINICAL MANAGEMENT OF CHRONIC HEART-FAILURE WITH BETA-BLOCKING-AGENTS [J].

BRISTOW, MR .

AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (09) :C12-C22

[7] CHANGES IN MYOCARDIAL AND VASCULAR RECEPTORS IN HEART-FAILURE [J].

BRISTOW, MR .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) :A61-A71

[8]

BRISTOW MR, 1989, MOL PHARMACOL, V35, P295

[9] BETA-ADRENERGIC NEUROEFFECTOR ABNORMALITIES IN THE FAILING HUMAN HEART ARE PRODUCED BY LOCAL RATHER THAN SYSTEMIC MECHANISMS [J].

BRISTOW, MR ;

MINOBE, W ;

RASMUSSEN, R ;

LARRABEE, P ;

SKERL, L ;

KLEIN, JW ;

ANDERSON, FL ;

MURRAY, J ;

MESTRONI, L ;

KARWANDE, SV ;

FOWLER, M ;

GINSBURG, R .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) :803-815

[10] DIFFERENCES IN BETA-ADRENERGIC NEUROEFFECTOR MECHANISMS IN ISCHEMIC VERSUS IDIOPATHIC DILATED CARDIOMYOPATHY [J].

BRISTOW, MR ;

ANDERSON, FL ;

PORT, JD ;

SKERL, L ;

HERSHBERGER, RE ;

LARRABEE, P ;

OCONNELL, JB ;

RENLUND, DG ;

VOLKMAN, K ;

MURRAY, J ;

FELDMAN, AM .

CIRCULATION, 1991, 84 (03) :1024-1039

← 1 2 3 4 →